Ginkgo Bioworks Holdings (DNABW) Amortization of Goodwill (2024)
Ginkgo Bioworks Holdings (DNABW) reported Amortization of Goodwill of -$42000.0 for Q4 2024, down 100.09% quarter-over-quarter from $47.9 million in Q2 2024.
Ginkgo Bioworks Holdings (DNABW) Amortization of Goodwill (2024) Analysis & Trends
Ginkgo Bioworks Holdings has reported Amortization of Goodwill for 1 years, with the latest figure at -$42000.0 in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Goodwill changed N/A year-over-year to -$42000.0; the trailing twelve-month figure through Dec 2025 stood at -$42000.0 (down 100.09% YoY), and the FY2024 full-year result was $47.9 million, changed N/A from the prior year.
- Amortization of Goodwill for Q4 2024 stood at -$42000.0, down from $47.9 million in the prior quarter.
- The five-year high for Amortization of Goodwill was $47.9 million in Q2 2024, with the low at -$42000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | - | - | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -42,000.00 |
| Dec 31, 2024 | -42,000.00 |
| Jun 30, 2024 | 47.90 Mn |
| Jun 30, 2024 | 47.90 Mn |